Lobbying Spend
—
Filings
22
Firms Hired
1
Active Period
2006–2012
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
SMA Treatment Acceleration Act of 2009
2010 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2149
SMA Treatment Acceleration Act of 2009
2010 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases
Client expense: — · Firm income: $30,000
Matched citations: S. 1158
SMA Treatment Acceleration Act of 2009
2010 · third_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2149
SMA Treatment Acceleration Act of 2009
2010 · third_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases
Client expense: — · Firm income: $30,000
Matched citations: S. 1158
SMA Treatment Acceleration Act of 2009
2010 · second_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2149
SMA Treatment Acceleration Act of 2009
2010 · second_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act Tracking NIH and FDA activities on rare diseases
Client expense: — · Firm income: $30,000
Matched citations: S. 1158
SMA Treatment Acceleration Act of 2009
2010 · first_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2149
SMA Treatment Acceleration Act of 2009
2010 · first_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: S. 1158
Early Treatment for HIV Act of 2007
2009 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
H.R. 3293 FY10 Labor HHS and Education Appropriations funding for NIH H.R. 3326 FY10 Defense Appropriations funding for medical research
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3326
SMA Treatment Acceleration Act of 2009
2009 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2149
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
2009 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
H.R. 3293 FY10 Labor HHS and Education Appropriations funding for NIH H.R. 3326 FY10 Defense Appropriations funding for medical research
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3293
SMA Treatment Acceleration Act of 2009
2009 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: S. 1158
Early Treatment for HIV Act of 2007
2009 · third_quarter · Firm: WINNING STRATEGIES WASHINGTON
H.R. 3293 FY10 Labor HHS and Education Appropriations funding for NIH H.R. 3326 FY10 Defense Appropriations funding for medical research
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3326
SMA Treatment Acceleration Act of 2009
2009 · third_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2149
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
2009 · third_quarter · Firm: WINNING STRATEGIES WASHINGTON
H.R. 3293 FY10 Labor HHS and Education Appropriations funding for NIH H.R. 3326 FY10 Defense Appropriations funding for medical research
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3293
SMA Treatment Acceleration Act of 2009
2009 · third_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: S. 1158
SMA Treatment Acceleration Act of 2009
2009 · second_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2149
SMA Treatment Acceleration Act of 2009
2009 · second_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 2149, S. 1158 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: S. 1158
SMA Treatment Acceleration Act
2009 · first_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3334
Veterans Stamp to Honor American Veterans Act
2009 · first_quarter · Firm: WINNING STRATEGIES WASHINGTON
S. 3230 FY09 Labor HHS and Education Appropriations funding for NIH FY09 Defense Appropriations and H.R. 2638 Continuing Resolution funding for medical research
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2638
SMA Treatment Acceleration Act
2009 · first_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: S. 2042
S. 3230 FY09 Labor HHS and Education Appropriations funding for NIH FY09 Defense Appropriations and H.R. 2638 Continuing Resolution funding for medical research
Client expense: — · Firm income: $30,000
Matched citations: S. 3230
Small Business Expensing Permanency Act of 2003
2008 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
S. 3230 FY09 Labor HHS and Education Appropriations funding for NIH FY09 Defense Appropriations and H.R. 2638 Continuing Resolution funding for medical research
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2638
SMA Treatment Acceleration Act
2008 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3334
SMA Treatment Acceleration Act
2008 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: — · Firm income: $30,000
Matched citations: S. 2042
Source: Senate LDA